HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer’s disease

por Festoff, Barry W., Sajja, Ravi K., van Dreden, Patrick, Cucullo, Luca
Publicado en J Neuroinflammation (2016)

Procoagulant Phospholipids and Tissue Factor Activity in Cerebrospinal Fluid from Patients with Intracerebral Haemorrhage

por Van Dreden, Patrick, Hue, Guy, Dreyfus, Jean-François, Woodhams, Barry, Vasse, Marc
Publicado 2014

Prospective Assessment of Biomarkers of Hypercoagulability for the Identification of Patients With Severe Coronary Artery Disease. The ROADMAP-CAD Study

por Gerotziafas, Grigoris T., Zografos, Theodoros, Pantos, Ioannis, Lefkou, Eleftheria, Carlo, Audrey, Fareed, Jawed, Van Dreden, Patrick, Katritsis, Demosthenes
Publicado en Clin Appl Thromb Hemost (2020)

Comparison of antithrombin‐dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clots

por Salta, Stella, Papageorgiou, Loula, Larsen, Annette K., Van Dreden, Patrick, Soulier, Claire, Cokkinos, Dennis V., Elalamy, Ismail, Gerotziafas, Grigoris T.
Publicado en Res Pract Thromb Haemost (2018)

Graft Product for Autologous Peripheral Blood Stem Cell Transplantation Enhances Thrombin Generation and Expresses Procoagulant Microparticles and Tissue Factor

por Sidibe, Fatoumata, Spanoudaki, Anastasia, Vanneaux, Valerie, Mbemba, Elisabeth, Larghero, Jerome, Van Dreden, Patrick, Lotz, Jean-Pierre, Elalamy, Ismail, Larsen, Annette K., Gerotziafas, Grigoris T.
Publicado en Clin Appl Thromb Hemost (2017)

Impact of blood hypercoagulability on in vitro fertilization outcomes: a prospective longitudinal observational study

por Gerotziafas, Grigoris T., Van Dreden, Patrick, Mathieu d’Argent, Emmanuelle, Lefkou, Eleftheria, Grusse, Matthieu, Comtet, Marjorie, Sangare, Rabiatou, Ketatni, Hela, Larsen, Annette K., Elalamy, Ismail
Publicado en Thromb J (2017)

Thrombin Generation Profile in Patients With Steady State Peripheral Arterial Disease

por Liew, Aaron, Failla, Giacomo, Molinari, Giulia, Prior, Manlio, Zalunardo, Beniamino, Pergolini, Daniela, Knavs, Katja, Kozak, Matija, Cortelazzo, Adriano, Van Dreden, Patrick, Elalamy, Ismail, Catalano, Mariella, Gerotziafas, Grigoris T.
Publicado en Clin Appl Thromb Hemost (2017)

Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process

por Papageorgiou, Loula, Alhaj Hussen, Kutaiba, Thouroude, Sandrine, Mbemba, Elisabeth, Cost, Héléne, Garderet, Laurent, Elalamy, Ismail, Larsen, Annette, Van Dreden, Patrick, Dimopoulos, Meletios A., Mohty, Mohamad, Gerotziafas, Grigoris T.
Publicado en TH Open (2019)

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

por Elalamy, Ismail, Gerotziafas, Grigoris, Alamowitch, Sonia, Laroche, Jean-Pierre, Van Dreden, Patrick, Ageno, Walter, Beyer-Westendorf, Jan, Cohen, Alexander T., Jimenez, David, Brenner, Benjamin, Middeldorp, Saskia, Cacoub, Patrice
Publicado en Thromb Haemost (2021)

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer‐Associated Throm...

por Syrigos, Konstantinos, Grapsa, Dimitra, Sangare, Rabiatou, Evmorfiadis, Ilias, Larsen, Annette K., Van Dreden, Patrick, Boura, Paraskevi, Charpidou, Andriani, Kotteas, Elias, Sergentanis, Theodoros N., Elalamy, Ismail, Falanga, Anna, Gerotziafas, Grigoris T.
Publicado en Oncologist (2018)

Longer procoagulant phospholipid-dependent clotting time, lower endogenous thrombin potential and higher tissue factor pathway inhibitor concentrations are associated with increase...

por Fotiou, Despina, Sergentanis, Theodoros N., Papageorgiou, Loula, Stamatelopoulos, Kimon, Gavriatopoulou, Maria, Kastritis, Efstathios, Psaltopoulou, Theodora, Salta, Stella, Van Dreden, Patrick, Sangare, Rabiatou, Larsen, Annette K., Terpos, Evangelos, Elalamy, Ismail, Dimopoulos, Meletios A., Gerotziafas, Grigoris T.
Publicado en Blood Cancer J (2018)

Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability

por Chaari, Mourad, Ayadi, Ines, Rousseau, Aurelie, Lefkou, Eleftheria, Van Dreden, Patrick, Sidibe, Fatoumata, Ketatni, Hela, Galea, Vassiliki, Khaterchi, Amir, Bouzguenda, Racem, Frikha, Mounir, Ghorbal, Lilia, Daoud, Jamel, Kallel, Choumous, Quinn, Martin, Gligorov, Joseph, Lotz, Jean Pierre, Hatmi, Mohamed, Elalamy, Ismail, Gerotziafas, Grigoris T
Publicado en BMC Cancer (2014)

Antibody-based targeting of alternatively spliced tissue factor: a new approach to impede the primary growth and spread of pancreatic ductal adenocarcinoma

por Unruh, Dusten, Ünlü, Betül, Lewis, Clayton S., Qi, Xiaoyang, Chu, Zhengtao, Sturm, Robert, Keil, Ryan, Ahmad, Syed A., Sovershaev, Timofey, Adam, Mariette, Van Dreden, Patrick, Woodhams, Barry J., Ramchandani, Divya, Weber, Georg F., Rak, Janusz W., Wolberg, Alisa S., Mackman, Nigel, Versteeg, Henri H., Bogdanov, Vladimir Y.
Publicado en Oncotarget (2016)